Weight boss? Competition for Novo Nordisk

This episode of The Intelligence from The Economist covers two main stories: the competition between Novo Nordisk and Eli Lilly in the weight loss drug market, detailing Novo Nordisk's missteps and strategic changes, and a look into the British wool industry, exploring its historical significance, recent price increases due to demand and supply factors, and the impact of sheep well-being on wool quality. The podcast analyzes market dynamics, corporate strategies, and economic trends in these distinct sectors.